Long-term Psychiatric and Endocrine Complications Following Hematopoietic Stem Cell Transplantation in Hematologic Disease in Korea: A Nation-Wide Cohort Study

被引:0
作者
Jeon, Min Ji [1 ]
Noh, Eunjin [2 ]
Moon, Seok Joo [2 ]
Yu, Eun Sang [1 ]
Choi, Chul Won [1 ]
Kim, Dae Sik [1 ]
Kang, Eun Joo [1 ]
机构
[1] Korea Univ, Coll Med, Dept Internal Med, Div Hematooncol,Guro Hosp, 148 Gurodong Ro, Seoul 08308, South Korea
[2] Korea Univ, Coll Med, Guro Hosp, Smart Healthcare Ctr, Seoul, South Korea
来源
CANCER RESEARCH AND TREATMENT | 2024年 / 56卷 / 04期
关键词
Hematopoietic stem cell transplantation; Complication; Diabetes mellitus; Depressive disorder; IMPAIRED GLUCOSE-TOLERANCE; DIABETES-MELLITUS; SURVIVORS; SOCIETY; BLOOD;
D O I
10.4143/crt.2024.047
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Numerous patients experience long-term complications after hematopoietic stem cell transplantation (HSCT). This study aimed to identify the frequency and risk factors for psychiatric and endocrine complications following HSCT through big data analyses. Materials and Methods We established a cohort of patients with hematologic disease who underwent HSCT in Korea between 2010 and 2012 using the Health Insurance Review & Assessment Service data. A total of 3,636 patients were identified, and insurance claims were tracked using psychiatric and endocrine diagnostic International Classification of Diseases, 10th Revision codes for the ensuing decade. We identified the incidence rates of long-term complications based on the baseline disease and HSCT type. Prognostic factors for each complication were scrutinized using logistic regression analysis. Results A total of 1,879 patients underwent allogeneic HSCT and 1,757 patients received autologous HSCT. Post-HSCT, 506 patients were diagnosed with depression, 465 with anxiety disorders, and 659 with diabetes. The highest incidence of long-term complications occurred within the first year post-HSCT (12.2%), subsequently decreasing over time. Risk factors for depressive disorders after allogeneic HSCT included female sex, a total body irradiation-based conditioning regimen, and cyclosporine. Identified risk factors for diabetes mellitus comprised old age, total body irradiation-based conditioning regimen, and non-antithymocyte globulin protocol. Regarding autologous HSCT, only female sex was identified as a risk factor for depressive disorders, whereas elderly patients and those with multiple myeloma were identified as poor prognostic factors for diabetes mellitus. Conclusion The incidence of long-term psychiatric and endocrine complications post-HSCT remains high, and patients with risk factors for these complications require vigilant follow-up.
引用
收藏
页码:1262 / 1269
页数:8
相关论文
共 30 条
[1]   A review of late complications of allogeneic hematopoietic stem cell transplantations [J].
Atilla, Erden ;
Atilla, Pinar Ataca ;
Toprak, Selami Kocak ;
Demirer, Taner .
CLINICAL TRANSPLANTATION, 2017, 31 (10)
[2]   Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study [J].
Baker, K. Scott ;
Ness, Kirsten K. ;
Steinberger, Julia ;
Carter, Andrea ;
Francisco, Liton ;
Burns, Linda J. ;
Sklar, Charles ;
Forman, Stephen ;
Weisdorf, Daniel ;
Gurney, James G. ;
Bhatia, Smita .
BLOOD, 2007, 109 (04) :1765-1772
[3]   Distinctive characteristics of diabetes mellitus after hematopoietic cell transplantation during childhood [J].
Bonanomi, Sonia ;
Gaiero, Alberto ;
Masera, Nicoletta ;
Rovelli, Attilio ;
Uderzo, Cornelio ;
Fichera, Graziella ;
Mulas, Roberta ;
Zecca, Silvia ;
Pozzi, Lorena ;
Cohen, Amnon .
PEDIATRIC TRANSPLANTATION, 2006, 10 (04) :461-465
[4]   Endocrine complications of hematopoietic stem cell transplantation [J].
Chemaitilly, Wassim ;
Sklar, Charles A. .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2007, 36 (04) :983-+
[5]   Late complications and quality of life assessment for survivors receiving allogeneic hematopoietic stem cell transplantation [J].
Cheon, Jaekyung ;
Lee, Yoo Jin ;
Jo, Jae-Cheol ;
Kweon, Kukju ;
Koh, SuJin ;
Min, Young Ju ;
Park, Sang-Hyuk ;
Lee, Sin-hye ;
Kim, Hyo-jin ;
Choi, Yunsuk .
SUPPORTIVE CARE IN CANCER, 2021, 29 (02) :975-986
[6]   Current Use of and Trends in Hematopoietic Cell Transplantation in the United States [J].
D'Souza, Anita ;
Fretham, Caitrin ;
Lee, Stephanie J. ;
Arora, Mukta ;
Brunner, Janet ;
Chhabra, Saurabh ;
Devine, Steven ;
Eapen, Mary ;
Hamadani, Mehdi ;
Hari, Parameswaran ;
Pasquini, Marcelo C. ;
Perez, Waleska ;
Phelan, Rachel A. ;
Riches, Marcie L. ;
Rizzo, J. Douglas ;
Saber, Wael ;
Shaw, Bronwen E. ;
Spellman, Stephen R. ;
Steinert, Patricia ;
Weisdorf, Daniel J. ;
Horowitz, Mary M. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (08) :E177-E182
[7]   Dose intensity for conditioning in allogeneic hematopoietic cell transplantation: can we recommend "when and for whom" in 2021? [J].
Gagelmann, Nico ;
Kroeger, Nicolaus .
HAEMATOLOGICA, 2021, 106 (07) :1794-1804
[8]   Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time [J].
Gratwohl, A ;
Brand, R ;
Frassoni, F ;
Rocha, V ;
Niederwieser, D ;
Reusser, P ;
Einsele, H ;
Cordonnier, C .
BONE MARROW TRANSPLANTATION, 2005, 36 (09) :757-769
[9]   DIABETES MELLITUS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION [J].
Griffith, Michelle L. ;
Jagasia, Madan ;
Jagasia, Shubhada M. .
ENDOCRINE PRACTICE, 2010, 16 (04) :699-706
[10]   Risk factors for diabetes mellitus and impaired glucose tolerance following allogeneic hematopoietic stem cell transplantation in pediatric patients with hematological malignancies [J].
Hirabayashi, Kanae ;
Nakazawa, Yozo ;
Matsuura, Hiroki ;
Hara, Yosuke ;
Kurata, Takashi ;
Hirabayashi, Koichi ;
Saito, Shoji ;
Yoshikawa, Kentaro ;
Tanaka, Miyuki ;
Yanagisawa, Ryu ;
Sakashita, Kazuo ;
Koike, Kenichi .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (04) :477-486